We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1101
Natera
NTRA
$37B
– –
-5,463
Closed -$592K
NTRS icon
1102
Northern Trust
NTRS
$22.4B
– –
-10,083
Closed -$847K
NVAX icon
1103
Novavax
NVAX
$1.23B
– –
-20,221
Closed -$256K
NVCR icon
1104
NovoCure
NVCR
$1.97B
– –
-21,042
Closed -$360K
NXRT
1105
NexPoint Residential Trust
NXRT
$671M
– –
-8,546
Closed -$338K
OGS icon
1106
ONE Gas
OGS
$5.02B
– –
-11,337
Closed -$724K
ON icon
1107
ON Semiconductor
ON
$34.7B
– –
-8,959
Closed -$614K
ONL
1108
Orion Office REIT
ONL
$150M
– –
-49,265
Closed -$177K
OPCH icon
1109
Option Care Health
OPCH
$3.42B
– –
-22,011
Closed -$610K
ORCL icon
1110
Oracle
ORCL
$345B
– –
-19,899
Closed -$2.81M
ORLY icon
1111
O'Reilly Automotive
ORLY
$75.1B
– –
-3,060
Closed -$215K
OVV icon
1112
Ovintiv
OVV
$16.6B
– –
-49,136
Closed -$2.3M
PATH icon
1113
UiPath
PATH
$6.02B
– –
-29,509
Closed -$374K
PCOR icon
1114
Procore
PCOR
$7.03B
– –
-7,999
Closed -$530K
PEG icon
1115
Public Service Enterprise Group
PEG
$39.5B
– –
-11,917
Closed -$878K
PEN icon
1116
Penumbra
PEN
$12.6B
– –
-4,681
Closed -$842K
PFG icon
1117
Principal Financial Group
PFG
$24B
– –
-22,502
Closed -$1.77M
PFSI icon
1118
PennyMac Financial
PFSI
$4.39B
– –
-8,833
Closed -$836K
PGR icon
1119
Progressive
PGR
$125B
– –
-6,797
Closed -$1.41M
PH icon
1120
Parker-Hannifin
PH
$124B
– –
-2,355
Closed -$1.19M
PHIN icon
1121
Phinia Inc
PHIN
$2.91B
– –
-11,331
Closed -$446K
PLAB icon
1122
Photronics
PLAB
$1.76B
– –
-10,076
Closed -$249K
PLAY icon
1123
Dave & Buster's
PLAY
$363M
– –
-8,124
Closed -$323K
PLRX icon
1124
Pliant Therapeutics
PLRX
$66.9M
– –
-24,904
Closed -$268K
POOL icon
1125
Pool Corp
POOL
$6.73B
– –
-1,917
Closed -$589K
43 44
45
46 47

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.